Skip to content

Streptozocin

Zanosar (streptozocin) is a small molecule pharmaceutical. Streptozocin was first approved as Zanosar on 1982-05-07. It is used to treat colorectal neoplasms, hodgkin disease, and islet cell carcinoma in the USA.
Trade Name Zanosar
Common Name Streptozocin
Indication colorectal neoplasms, hodgkin disease, islet cell carcinoma
Drug Class
Streptozocin
Get full access now